- Home
- UTMD vs PRQR Comparison
UTMD vs PRQR Comparison
Compare UTMD & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UTMD | PRQR |
|---|---|---|
| Founded | 1978 | 2012 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 196.4M | 167.5M |
| IPO Year | 1994 | 2014 |
Fundamental Metrics
Financial Performance| Metric | UTMD | PRQR |
|---|---|---|
| Price | $62.87 | $1.71 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $6.80 |
| AVG Volume (30 Days) | 10.1K | ★ 366.8K |
| Earning Date | 04-28-2026 | 03-12-2026 |
| Dividend Yield | ★ 2.00% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.48 | N/A |
| Revenue | ★ $38,520,000.00 | N/A |
| Revenue This Year | N/A | $18.88 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $17.81 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $51.27 | $1.08 |
| 52 Week High | $68.71 | $3.10 |
Technical Indicators
Market Signals| Indicator | UTMD | PRQR |
|---|---|---|
| Relative Strength Index (RSI) | 46.29 | 54.29 |
| Support Level | $62.22 | $1.33 |
| Resistance Level | $64.21 | $1.80 |
| Average True Range (ATR) | 2.11 | 0.13 |
| MACD | -0.22 | -0.00 |
| Stochastic Oscillator | 31.61 | 71.00 |
Price Performance
Historical ComparisonAbout UTMD Utah Medical Products Inc.
Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable, and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, and Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals, and outpatient clinics and physicians' offices.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.